EUVIMEDEUVIMED entdecken
Leserbrief

Comparison of IPAQ‐SF Self‐Reported and Fitbit‐Measured Physical Activity in Young People With Haemophilia

Ruth Elise D Matlary, Pål André Holme, Corina S Rueegg, Heidi Glosli, May Grydeland

Haemophilia · 2026-05 · 32 (3) · 854-858

DOI: 10.1111/hae.70243 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Haemophilia, online erschienen am 12.03.2026. Verfasst von Ruth Elise D Matlary und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Oslo University Hospital, Oslo, Norway. Die Arbeit nennt 11 Literaturangaben. Gefördert von: Bayer HealthCare.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dear Editor: It is well known that physical activity (PA) can provide several health benefits to people with haemophilia (PWH), and regular PA is therefore encouraged [1]. Largely, the same PA recommendations as for the general population apply also to this patient group [2, 3]. In order to obtain information about PA levels, such as mapping, tracking of changes, and classifying people as being sufficiently physically active or not, some sort of measurement is required. Self-reported measurements by questionnaires are commonly used for this purpose, and a systematic review from 2021 highlighted that, up until then, the majority of investigations into PA among PWH had utilised self-report methods [4]. However, self-reported PA is subject to recall- and potential social desirability bias, as well as measurement imprecision compared to more objective assessments [5]. The International Physical Activity Questionnaire Short Form (IPAQ-SF) is a frequently utilised questionnaire, even though its correlation with objective measures of PA are mostly below the acceptable threshold [6]. Objective measurements (e.g., via use of validated wearable devices/activity trackers paired with standardised protocols) are potentially more accurate, and therefore recommended for more precise PA estimates [7]. Nonetheless, we chose to include IPAQ-SF as an assessment method in our study to enable comparison to an activity tracker, and to allow comparison to results from other studies where this questionnaire has been utilised. In the current study, we aimed to compare IPAQ-SF self-reported and Fitbit-measured PA in PWH. For this purpose, we used data collected through the ‘HemFitbit study’ (ClinicalTrials.gov NCT04181697), where PA data was captured using both self-report and activity trackers. Ethical approval was obtained from the Regional Committee for Medical and Health Research Ethics South East and the Oslo University Hospital Data Protection Officer. All participants (and/or guardians) provided informed consent to participate. Forty PWH A, aged 13–30 years, with moderate or severe haemophilia A on continuous prophylaxis and without inhibitors were included. PA outcomes were average daily minutes of; light (LPA), moderate (MPA), vigorous (VPA), moderate-to-vigorous (MVPA = MPA + VPA) and total (PA = LPA + MPA + VPA). For self-reported PA, the Norwegian version of the IPAQ-SF was used. As prompted in the questionnaire, participants reported time spent in VPA, MPA, and walking, of at least 10-minutes duration, for the last seven days. Because the IPAQ-SF does not have a specific question for LPA, we defined walking as LPA for our comparison. Participants responding ‘don't know/unsure’ to questions were excluded. Objective PA outcomes were collected using the activity tracker Fitbit Charge 3 (Fitbit Inc, San Francisco, California, USA) over a 12-week measurement period for each participant. Invalid days, defined as ≤1,000 steps/day, were excluded (more details about the Fitbit measurements can be found in a previous publication: [8]). One overall daily average per PA outcome was computed per participant for IPAQ-SF and Fitbit based on valid responses/days, in order to get an estimate of habitual daily PA. Statistical analyses were conducted using Stata version 18.0 (StataCorp LLC, College Station, TX, USA). Except for the age variable, data were non-normally distributed. For continuous variables, we used descriptive statistics (mean and standard deviation (SD) for normally distributed variables and medians and interquartile ranges (IQR) for non-normally distributed variables), Spearman's correlation and Bland-Altman plots with 95% limits of agreement (LoA) (2.fifth centile and 97.fifth centile) to compare IPAQ-SF self-reported and Fitbit-measured PA. If there were complete agreement between the two methods, all data points would lie at a horizontal line at zero. Linear regression models were used to test whether the slope of the Bland-Altman regression was significantly different from zero. A p-value of

Autor:innen und Institutionen

  • Department of Haematology, Oslo University Hospital, Oslo, Norway.
  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.
  • Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Norwegian Centre for Rare Diseases, Division for Paediatric and Adolescent medicine, Oslo University Hospital, Oslo, Norway.
  • Department of Physical Performance, Norwegian School of Sport Sciences, Oslo, Norway.

Förderung

  • Bayer HealthCare

Zitieren

APA

Matlary, R. E. D., Holme, P. A., Rueegg, C. S., Glosli, H., & Grydeland, M. (2026). Comparison of IPAQ‐SF Self‐Reported and Fitbit‐Measured Physical Activity in Young People With Haemophilia. Haemophilia, 32(3), 854-858. https://doi.org/10.1111/hae.70243

Vancouver

Matlary RED, Holme PA, Rueegg CS, Glosli H, Grydeland M. Comparison of IPAQ‐SF Self‐Reported and Fitbit‐Measured Physical Activity in Young People With Haemophilia. Haemophilia. 2026;32(3):854-858. doi:10.1111/hae.70243

BibTeX
@article{Matlary2026,
  author = {Matlary, Ruth Elise D and Holme, Pål André and Rueegg, Corina S and Glosli, Heidi and Grydeland, May},
  title = {Comparison of IPAQ‐SF Self‐Reported and Fitbit‐Measured Physical Activity in Young People With Haemophilia},
  journal = {Haemophilia},
  year = {2026},
  volume = {32},
  number = {3},
  pages = {854--858},
  doi = {10.1111/hae.70243}
}
Kostenlos starten →